The lactate-to-albumin ratio as a potential biomarker for short-term mortality risk in critically ill patients with urosepsis: a retrospective study with dual-cohort validation

The LAR is a cost-effective supplementary predictor of short-term mortality risk in critically ill urosepsis patients, primarily aiding early identification of high-risk cases to intensify monitoring and treatment. Its clinical value require further prospective validation.